Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Cardiff Oncology (CRDF) over the last 16 years, with Q3 2025 value amounting to $956000.0.

  • Cardiff Oncology's Prepaid Assets fell 869.15% to $956000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $956000.0, marking a year-over-year decrease of 869.15%. This contributed to the annual value of $2.5 million for FY2024, which is 1016.95% up from last year.
  • Cardiff Oncology's Prepaid Assets amounted to $956000.0 in Q3 2025, which was down 869.15% from $2.2 million recorded in Q2 2025.
  • Cardiff Oncology's 5-year Prepaid Assets high stood at $6.0 million for Q1 2022, and its period low was $956000.0 during Q3 2025.
  • Moreover, its 5-year median value for Prepaid Assets was $2.5 million (2024), whereas its average is $3.1 million.
  • In the last 5 years, Cardiff Oncology's Prepaid Assets surged by 20507.5% in 2021 and then plummeted by 5613.8% in 2023.
  • Cardiff Oncology's Prepaid Assets (Quarter) stood at $4.8 million in 2021, then grew by 9.96% to $5.2 million in 2022, then plummeted by 56.14% to $2.3 million in 2023, then grew by 10.17% to $2.5 million in 2024, then tumbled by 62.29% to $956000.0 in 2025.
  • Its last three reported values are $956000.0 in Q3 2025, $2.2 million for Q2 2025, and $2.4 million during Q1 2025.